E
Ultragenyx Pharmaceutical Inc. RARE
$29.78 $0.260.88% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 166.50M 139.29M 164.88M 139.49M 147.03M
Total Other Revenue -- -- -- -- --
Total Revenue 166.50M 139.29M 164.88M 139.49M 147.03M
Cost of Revenue 187.74M 194.43M 714.76M 21.02M 182.78M
Gross Profit -21.24M -55.14M -549.88M 118.47M -35.76M
SG&A Expenses 86.65M 87.80M 82.50M 80.35M 80.60M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 274.38M 282.23M 287.16M 271.48M 263.39M
Operating Income -107.89M -142.94M -122.28M -131.99M -116.36M
Income Before Tax -114.00M -149.77M -133.40M -133.21M -130.74M
Income Tax Expenses 947.00K 1.31M -19.00K 303.00K 858.00K
Earnings from Continuing Operations -114.95M -151.08M -133.39M -133.52M -131.60M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -114.95M -151.08M -133.39M -133.52M -131.60M
EBIT -107.89M -142.94M -122.28M -131.99M -116.36M
EBITDA -99.27M -133.95M -113.20M -123.23M -107.50M
EPS Basic -1.17 -1.57 -1.39 -1.40 -1.52
Normalized Basic EPS -0.72 -0.97 -0.86 -0.88 -0.92
EPS Diluted -1.17 -1.57 -1.39 -1.40 -1.52
Normalized Diluted EPS -0.72 -0.97 -0.86 -0.88 -0.92
Average Basic Shares Outstanding 98.46M 96.29M 95.68M 95.49M 86.58M
Average Diluted Shares Outstanding 98.46M 96.29M 95.68M 95.49M 86.58M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --